Will the FDA approve baxdrostat for hard-to-control hypertension?
Prediction market on kalshi. If the FDA approves baxdrostat for hard-to-control hypertension for marketing before Aug 1, 2026, then the market resolves to Yes.
Resolves: 8/8/2026.
Will the FDA approve baxdrostat for hard-to-control hyperten | Blockcircle